Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Francis Crick Institute, 1 Midland Rd, London NW1 1AT

  1. Events
  2. Venues
  3. Francis Crick Institute, 1 Midland Rd, London NW1 1AT
Events at this venue
Today

Precision Medicine in Oncology

CSEN, in partnership with Cancer Research UK (CRUK), Cancer Research Horizons (CRH), Capital Enterprise, and Cancer Tech Accelerator (CTA), is hosting an afternoon dedicated to [...]

Contractors

Timesheet Portal

Clients
Legal
Contact Us

Copyright © 2025 | Hlx Life Sciences

Site by theLEAP

Go to Top